Lexington, KY, United States of America

Ziyuan Zhou

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ziyuan Zhou

Introduction

Ziyuan Zhou is a prominent inventor based in Lexington, KY (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target inflammation. With a total of three patents to his name, Zhou's work is recognized for its potential impact on treating inflammation-related disorders.

Latest Patents

Zhou's latest patents focus on prostaglandin E synthase inhibitors and methods for utilizing these compounds. These inventions provide compositions that can inhibit microsomal prostaglandin E synthase-1 (mPGES-1). The compounds are designed to reduce inflammation in subjects suffering from various inflammatory disorders. Additionally, pharmaceutical compositions containing these compounds are also included in his patents. The methods outlined in his patents involve administering an effective amount of the composition to a subject to achieve the desired anti-inflammatory effects.

Career Highlights

Ziyuan Zhou is affiliated with the University of Kentucky Research Foundation, where he conducts his research and development work. His innovative approach to addressing inflammation has garnered attention in the scientific community. Zhou's dedication to advancing medical science is evident through his patent filings and ongoing research efforts.

Collaborations

Zhou collaborates with notable colleagues, including Chang-Guo Zhan and Fang Zheng. These partnerships enhance the research environment and contribute to the development of groundbreaking solutions in the field of inflammation treatment.

Conclusion

Ziyuan Zhou's contributions to the field of pharmaceutical sciences through his innovative patents highlight his commitment to improving health outcomes. His work in developing prostaglandin E synthase inhibitors is a testament to the potential of targeted therapies in managing inflammation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…